Abstract
Squamous cell carcinoma of the temporal bone is a rare, highly malignant, aggressive disease in an extremely difficult anatomic site with a very poor prognosis. The development of an evidence base for the efficacy of its treatment has been hampered by its rarity. This article reviews current opinion based on the recent literature.
MeSH terms
-
Bone Neoplasms / mortality*
-
Bone Neoplasms / pathology*
-
Bone Neoplasms / therapy
-
Carcinoma, Squamous Cell / mortality*
-
Carcinoma, Squamous Cell / pathology*
-
Carcinoma, Squamous Cell / therapy
-
Combined Modality Therapy
-
Female
-
Humans
-
Male
-
Neoplasm Staging
-
Prognosis
-
Rare Diseases
-
Risk Assessment
-
Survival Rate
-
Temporal Bone*